One of the main purposes of medical cost-benefit analyses is to
define the rational priorities in health care. This book
ambitiously undertakes to compare the cost-benefit analyses of
three countries: the United States, Germany and Israel.
Cardiovascular disease is focused on to provide a model case study,
but other areas also provide examples. The contribu- tions consider
in particular two recent developments. These are the increase in
comprehensive epidemiological data, es- pecially with regards to
risk factors, and improved methodo- logy for measuring the quality
of life. The contributions stem from clinicians, epidemiologists
and health economists who give an overall picture of these complex
issues and the prospects for the future.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!